{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T04:12:02Z","timestamp":1773115922007,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2014,10,29]],"date-time":"2014-10-29T00:00:00Z","timestamp":1414540800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1007\/s40264-014-0183-6","type":"journal-article","created":{"date-parts":[[2014,10,28]],"date-time":"2014-10-28T13:37:26Z","timestamp":1414503446000},"page":"19-31","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Liver Safety Assessment: Required Data Elements and Best Practices for Data Collection and Standardization in Clinical Trials"],"prefix":"10.1007","volume":"37","author":[{"given":"Mark I.","family":"Avigan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Einar S.","family":"Bjornsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markku","family":"Pasanen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raul J.","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul B.","family":"Watkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James H.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Merz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,10,29]]},"reference":[{"key":"183_CR1","doi-asserted-by":"crossref","unstructured":"Watkins PB, Merz M, Avigan M, et al. The clinical liver safety assessment best practices workshop: rationale, goals, accomplishments and the future. Drug Saf 2014. doi: 10.1007\/s40264-014-0181-8 .","DOI":"10.1007\/s40264-014-0181-8"},{"key":"183_CR2","doi-asserted-by":"crossref","unstructured":"Merz M, Lee K, Kullak-Ublick GA, et al. Methodology to assess clinical liver safety data. Drug Saf 2014. doi: 10.1007\/s40264-014-0184-5 .","DOI":"10.1007\/s40264-014-0184-5"},{"key":"183_CR3","doi-asserted-by":"crossref","unstructured":"Regev A, Seeff L, Merz M, et al. Causality assessment for suspected DILI during clinical phases of drug development. Drug Saf 2014. doi: 10.1007\/s40264-014-0185-4 .","DOI":"10.1007\/s40264-014-0185-4"},{"key":"183_CR4","doi-asserted-by":"crossref","unstructured":"Kullak-Ublick GA, Merz M, Griffel L, et al. Liver safety assessment in special populations (hepatitis B, C, and oncology trials). Drug Saf 2014. 10.1007\/s40264-014-0186-3 .","DOI":"10.1007\/s40264-014-0186-3"},{"issue":"6","key":"183_CR5","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/clpt.2011.58","volume":"89","author":"GP Aithal","year":"2011","unstructured":"Aithal GP, Watkins PB, Andrade RJ, et al. Case definition and phenotype standardization in drug-induced liver injury. Clin Pharm Ther. 2011;89(6):806\u201315.","journal-title":"Clin Pharm Ther"},{"issue":"11","key":"183_CR6","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/0895-4356(93)90101-6","volume":"46","author":"G Danan","year":"1993","unstructured":"Danan G, Benichou C. Causality assessment of adverse reactions to drugs- 1. A novel method based on the conclusions of international consensus meetings: Application to drug-induced liver injuries. J Clin Epidemiol. 1993;46(11):1323\u201330.","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"183_CR7","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/hep.23696","volume":"52","author":"RJ Fontana","year":"2010","unstructured":"Fontana RJ, Seeff LB, Andrade RJ, et al. Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop. Hepatology. 2010;52(2):730\u201342.","journal-title":"Hepatology"},{"key":"183_CR8","unstructured":"FDA Guidance for Industry, Drug-induced liver injury: Premarketing Clinical Evaluation. Issued Jul 2009. http:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM174090.pdf . Accessed 1 Feb 2013."},{"key":"183_CR9","unstructured":"FDA Guidance for Industry, Clinical Pharmacogenomics: Premarket Evaluation in Early-Phase Clinical Studies and Recommendations for Labeling. Issued Jan 2013. http:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM33716pdf . Accessed 1 Feb 2013."},{"issue":"5","key":"183_CR10","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.cgh.2010.02.008","volume":"8","author":"VK Agarwal","year":"2010","unstructured":"Agarwal VK, McHutchison JG, Hoofnagle JH. Important elements for the diagnosis of drug-induced liver injury. Clin Gastroenterol Hepatol. 2010;8(5):463\u201370.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"183_CR11","unstructured":"Livertox database. http:\/\/www.livertox.nih.gov\/ . Accessed 1 Feb 2013."},{"key":"183_CR12","unstructured":"Livertox database. https:\/\/livertox.niddk.nih.gov\/ImportantElements.aspx . Accessed 22 Jan 2013."},{"key":"183_CR13","unstructured":"CDISC Standards in the Regulatory Review Process, 26 Jan 2012. http:\/\/www.cdisc.org\/stuff\/contentmgr\/files\/0\/cafc9ec064e98791f925a575d4aafa44\/misc\/cdisc_standards_in_fda_submissions_2012_01_26pdf.pdf . Accessed 1 Feb 20."},{"issue":"3","key":"183_CR14","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2165\/11586600-000000000-00000","volume":"34","author":"PB Watkins","year":"2011","unstructured":"Watkins PB, Desai M, Berkowitz SD, et al. Evaluation of drug-induced serious hepatotoxicity (eDISH): application of this data organization approach to phase III clinicaltrials of rivaroxaban after total hip or knee replacement surgery. Drug Saf. 2011;34(3):243\u201352.","journal-title":"Drug Saf"},{"issue":"9 Suppl","key":"183_CR15","doi-asserted-by":"crossref","first-page":"50S","DOI":"10.1177\/0091270010376771","volume":"50","author":"PR Jadhav","year":"2010","unstructured":"Jadhav PR, Neal L, Florian J, et al. Antiviral Information Management System (AIMS): a prototype for operational innovation in drug development. J Clin Pharmacol. 2010;50(9 Suppl):50S\u20135S.","journal-title":"J Clin Pharmacol"},{"key":"183_CR16","unstructured":"SAS\u2014JMP Clinical. http:\/\/www.jmp.com\/software\/clinical\/ . Accessed 25 Feb 2013."},{"key":"183_CR17","unstructured":"SAS\u2014MAED Service. http:\/\/www.meddramsso.com\/files_acrobat\/MAED_FDA_jun-28.pdf . Accessed 5 Mar 2013."},{"key":"183_CR18","unstructured":"R statistical and graphical tools. http:\/\/www.r-project.org\/ . Accessed 5 Mar 2013."},{"key":"183_CR19","unstructured":"JReview. http:\/\/www.i-review.com\/jreview.html . Accessed 5 Mar 2013."}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40264-014-0183-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-014-0183-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-014-0183-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T13:12:23Z","timestamp":1551186743000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40264-014-0183-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,29]]},"references-count":19,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["183"],"URL":"https:\/\/doi.org\/10.1007\/s40264-014-0183-6","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,29]]}}}